Live attenuated Japanese encephalitis chimeric virus vaccine
JEC12
Phase 3 mab completed
Quick answer
Live attenuated Japanese encephalitis chimeric virus vaccine for Japanese Encephalitis is a Phase 3 program (mab) at Sanofi Pasteur with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sanofi Pasteur
- Indication
- Japanese Encephalitis
- Phase
- Phase 3
- Modality
- mab
- Status
- completed